Adaptin Bio, Inc. (OTCPK: APTN)
Health Care · Biotechnology · US
$—
— today · — 1Y
Adaptin Bio, Inc. (OTCPK: APTN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $57.89M.
trading between 5.60 and 6.27.
Tweenvest scores Adaptin Bio, Inc. across four factors: quality 47/100, value 62/100. Its strongest factor is value.
APTN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $57.89M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.63
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $6.27
- 52-week low
- $5.60
- Avg volume (3M)
- —
- Shares outstanding
- 9.23M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pharos iBio Co., Ltd.KOSDAQ: A388870 | $60.30M | ₩6,210.00 | -3.12% |
| Hemogenyx Pharmaceuticals PlcLSE: HEMO | $59.69M | £6.58 | -10.48% |
| Gossamer Bio, Inc.NasdaqGS: GOSS | $58.75M | $9.61 | +1.53% |
| Zelluna ASAOB: ZLNA | $58.51M | Nkr18.50 | -5.85% |
| Biosino Bio-Technology and Science IncorporationSEHK: 8247 | $57.71M | HK$3.13 | -0.32% |
| B&K Corporation LimitedSEHK: 2396 | $57.42M | HK$3.83 | -8.70% |
| Caribou Biosciences, Inc.NasdaqGS: CRBU | $57.12M | $0.53 | -4.86% |
| Anti-Microbial Savior BioteQ Co., Ltd.TPEX: 6864 | $56.85M | NT$48.70 | -2.60% |
Figures last refreshed Oct 18, 2026.